Cargando…
Familial Cancer Variant Prioritization Pipeline version 2 (FCVPPv2) applied to a papillary thyroid cancer family
Whole-genome sequencing methods in familial cancer are useful to unravel rare clinically important cancer predisposing variants. Here, we present improvements in our pedigree-based familial cancer variant prioritization pipeline referred as FCVPPv2, including 12 tools for evaluating deleteriousness...
Autores principales: | Kumar, Abhishek, Bandapalli, Obul Reddy, Paramasivam, Nagarajan, Giangiobbe, Sara, Diquigiovanni, Chiara, Bonora, Elena, Eils, Roland, Schlesner, Matthias, Hemminki, Kari, Försti, Asta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072708/ https://www.ncbi.nlm.nih.gov/pubmed/30072699 http://dx.doi.org/10.1038/s41598-018-29952-z |
Ejemplares similares
-
Whole Genome Sequencing Prioritizes CHEK2, EWSR1, and TIAM1 as Possible Predisposition Genes for Familial Non-Medullary Thyroid Cancer
por: Srivastava, Aayushi, et al.
Publicado: (2021) -
Pedigree based DNA sequencing pipeline for germline genomes of cancer families
por: Försti, Asta, et al.
Publicado: (2016) -
Cancer Predisposition Genes in Cancer-Free Families
por: Zheng, Guoqiao, et al.
Publicado: (2020) -
Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways
por: Srivastava, Aayushi, et al.
Publicado: (2019) -
A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer
por: Srivastava, Aayushi, et al.
Publicado: (2020)